Form 8-K - Current report:
SEC Accession No. 0000200406-22-000004
Filing Date
2022-01-06
Accepted
2022-01-06 16:51:56
Documents
13
Period of Report
2022-01-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K jnj-20220106.htm   iXBRL 8-K 48110
  Complete submission text file 0000200406-22-000004.txt   257222

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnj-20220106.xsd EX-101.SCH 3542
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnj-20220106_def.xml EX-101.DEF 17377
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnj-20220106_lab.xml EX-101.LAB 35650
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnj-20220106_pre.xml EX-101.PRE 18240
7 EXTRACTED XBRL INSTANCE DOCUMENT jnj-20220106_htm.xml XML 21030
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0102
Type: 8-K | Act: 34 | File No.: 001-03215 | Film No.: 22515405
SIC: 2834 Pharmaceutical Preparations